Most Recent
The finance arm of luxury car maker BMW has been given the greenlight to repossess a red 2019 Ferrari 488 Pista Coupe purchased by alleged fraudster Bill Papas' defunct Forum Group.
Shine and Phi Finney McDonald’s fallback plan to cooperatively run a class action against Nuix has come under fire, with the technology company urging the court to make the two firms compete against one another for sole carriage.
A court has ordered a consultant at Kahlbetzer family investment vehicle Twynam Investments to pay a $30,000 judgment for allegedly breaching confidentiality obligations in her contract.
A Melbourne-based barristers' clerk has filed a lawsuit alleging her employment was terminated after she asked to work from home to manage her disability and was absent from work due to COVID-19 complications.
Investment manager Payton Securities has lost a bid to recoup claimed losses over $1.4 million stemming from an allegedly negligent property valuation by Bertacco Ferrier, with a judge finding that the company had not retained the valuer and was not a party to the valuation.
A long-serving Virgin Australia flight attendant who was found sleeping on the job was unfairly sacked given the length of her employment with the airline, the Fair Work Commission has found.
Broadcaster Seven has filed court proceedings against a production firm it partners with to broadcast the Olympic Games for allegedly refusing to hand over software it needs for the upcoming Commonwealth Games.
The lead applicants in a climate change class action by Torres Strait Islanders are hoping the Commonwealth will admit climate change targets set by the Morrison government were “woefully inadequate”, a court heard Friday.
Booktopia has resolved a case by the consumer regulator alleging the online book retailer's policy that required customers to request a refund within two business days of purchase was misleading.
German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.